000963 華東醫藥
按盤價 
38.980 +2.480 (+6.795%)
38.980 +2.480 (+6.795%) | 2024/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 31,477,655 | 3.56% | 40,623,783 | 37,714,587 | 34,563,301 | 33,683,059 | |
| 減：營業總成本 | 28,288,812 | 2.72% | 37,081,915 | 34,568,570 | 31,727,336 | 30,666,230 | |
| 其中:營業成本 | 21,231,803 | 2.51% | 27,461,732 | 25,682,497 | 23,957,371 | 22,550,482 | |
| 財務費用 | 38,018 | -40.63% | 51,190 | 78,257 | 22,075 | 34,201 | |
| 資產減值損失 | -- | -- | (6,520) | (3,822) | (16,908) | (4,538) | |
| 公允價值變動收益 | -- | -- | (13,756) | 28,469 | -- | -- | |
| 投資收益 | (86,710) | -48.64% | (219,713) | (141,560) | (96,312) | (27,525) | |
| 其中：對聯營企業和合營企業的投資收益 | (54,563) | -62.45% | (188,391) | (115,619) | (53,433) | (10,826) | |
| 營業利潤 | 3,215,352 | 18.71% | 3,452,927 | 3,061,454 | 2,855,714 | 3,476,575 | |
| 利潤總額 | 3,133,884 | 16.58% | 3,465,986 | 3,031,124 | 2,827,535 | 3,453,391 | |
| 減：所得稅費用 | 571,279 | 15.51% | 619,589 | 498,499 | 488,907 | 543,674 | |
| 淨利潤 | 2,562,604 | 16.82% | 2,846,397 | 2,532,626 | 2,338,628 | 2,909,717 | |
| 減：非控股權益 | 278 | -93.83% | 7,536 | 33,411 | 36,996 | 89,855 | |
| 股東淨利潤 | 2,562,327 | 17.05% | 2,838,861 | 2,499,214 | 2,301,631 | 2,819,861 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 1.464 | 17.06% | 1.622 | 1.428 | 1.315 | 1.612 | |
| 每股派息 (元) * | 0.350 | -- | 0.580 | 0.290 | 0.290 | 0.230 | |
| 每股淨資產 (元) * | 12.564 | 8.60% | 11.997 | 10.592 | 9.475 | 8.355 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 29/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
